心房颤动抗栓治疗的药物选择及监测

[1] 中国人非瓣膜性心房颤动脑卒中危险因素的病例-对照研究 [J]. 中华内科杂志, 2003, (03) : 16 - 20

[2] 北京地区非瓣膜病心房颤动患者缺血性脑卒中发生率及影响因素的随访研究 [J]. 中华心血管病杂志, 2002, (03) : 40 - 42

[3] Placebo-controlled,ran-domised trial of warfarin and aspirin for prevention of thromboem-bolic complications in chronic atrial fibrillation.The Copenhagen AFASAK study. Petersen P,Boysen G,Godtfredsen J,et al. The Lancet . 1989

[4] Atrial fibrillation as an inde-pendent risk factor for stroke:the Framingham Study. Wolf PA,Abbott RD,Kannel WB. Stroke . 1991

[5] ACC/AHA/ESC2006guide-lines for the management of patients with atrial fibrillation. Valentin F,Lars ER,David S.et al. Circulation . 2006

[1] 中国人非瓣膜性心房颤动脑卒中危险因素的病例-对照研究 [J]. 中华内科杂志, 2003, (03) : 16 - 20

[2] 北京地区非瓣膜病心房颤动患者缺血性脑卒中发生率及影响因素的随访研究 [J]. 中华心血管病杂志, 2002, (03) : 40 - 42

[3] Placebo-controlled,ran-domised trial of warfarin and aspirin for prevention of thromboem-bolic complications in chronic atrial fibrillation.The Copenhagen AFASAK study. Petersen P,Boysen G,Godtfredsen J,et al. The Lancet . 1989

[4] Atrial fibrillation as an inde-pendent risk factor for stroke:the Framingham Study. Wolf PA,Abbott RD,Kannel WB. Stroke . 1991

[5] ACC/AHA/ESC2006guide-lines for the management of patients with atrial fibrillation. Valentin F,Lars ER,David S.et al. Circulation . 2006